 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Dehydrogenase
|
PDB id
|
|
|
|
1e6w
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.1.1.1.178
- 3-hydroxy-2-methylbutyryl-CoA dehydrogenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD+ = 2-methylacetoacetyl-CoA + NADH
|
 |
 |
 |
 |
 |
(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA
|
+
|
NAD(+)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
2-methylacetoacetyl-CoA
|
+
|
NADH
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.1.1.1.35
- 3-hydroxyacyl-CoA dehydrogenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH
|
 |
 |
 |
 |
 |
(S)-3-hydroxyacyl-CoA
|
+
|
NAD(+)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
3-oxoacyl-CoA
|
+
|
NADH
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
mitochondrion
|
3 terms
|
 |
|
Biological process
|
metabolic process
|
6 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
11 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
303:311-327
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
|
|
A.J.Powell,
J.A.Read,
M.J.Banfield,
F.Gunn-Moore,
S.D.Yan,
J.Lustbader,
A.R.Stern,
D.M.Stern,
R.L.Brady.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human type II hydroxyacyl-CoA dehydrogenase/amyloid-beta binding alcohol
dehydrogenase (HADH II/ABAD) is an oxidoreductase whose salient features include
broad substrate specificity, encompassing 3-hydroxyacyl-CoA derivatives,
hydroxysteroids, alcohols and beta-hydroxybutyrate, and the capacity to bind
amyloid-beta peptide, leading to propagation of amyloid-induced cell stress. In
this study, we examine the structure and enzymatic activity of the homologous
rat HADH II/ABAD enzyme. We report the crystal structure of rat HADH II/ABAD as
a binary complex with its NADH cofactor to 2.0 A resolution, as a ternary
complex with NAD(+) and 3-ketobutyrate (acetoacetate) to 1.4 A resolution, and
as a ternary complex with NADH and 17 beta-estradiol to 1.7 A resolution. This
first crystal structure of an HADH II confirms these enzymes are closely related
to the short-chain hydroxysteroid dehydrogenases and differ substantially from
the classic, type I 3-hydroxyacyl-CoA dehydrogenases. Binding of the
ketobutyrate substrate is accompanied by closure of the active site specificity
loop, whereas the steroid substrate does not appear to require closure for
binding. Despite the different chemical nature of the two bound substrates, the
presentation of chemical groups within the active site of each complex is
remarkably similar, allowing a general mechanism for catalytic activity to be
proposed. There is a characteristic extension to the active site that is likely
to accommodate the CoA moiety of 3-hydroxyacyl-CoA substrates. Rat HADH II/ABAD
also binds amyloid-beta (1-40) peptide with a K(D) of 21 nM, which is similar to
the interaction exhibited between this peptide and human HADH II/ABAD. These
studies provide the first structural insights into HADH II/ABAD interaction with
its substrates, and indicate the relevance of the rodent enzyme and associated
rodent models for analysis of HADH II/ABAD's physiologic and pathophysiologic
properties.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Co-factor binding and catalytic mechanism of rHADH II/ABAD. (a) Schematic diagram showing inter-
actions between NADH and rHADH II/ABAD. (b) Schematic diagram showing the proposed reaction mechanism of
rHADH II/ABAD, based on structural similarity to other SDR enzymes and mechanism previously proposed for
human 17b-hydroxysteroid dehydrogenase by Breton et al. (1996). The numbers adjacent to the hydrogen bonds (bro-
ken lines) are the distances in angstroms measured between these groups in the respective crystal structures.
|
 |
Figure 6.
Figure 6. Binding of CoA substrates to rHADH II.
The Figure shows a model of the expected conformation
of a bound acetoacetyl-CoA substrate. The C
a
trace of a
single subunit of rHADH II/ABAD is shown in pale
blue, with the co-factor in purple, acetoacetate group
(from the crystal structure of the 3-ketobutyrate com-
plex) in red, and the thioester-linked coenzyme A group
in green. The two phosphate groups of the CoA moiety
are labelled PA and PN, and adjacent conserved, posi-
tively charged amino acid residues are also shown and
labelled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
303,
311-327)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.E.Muirhead,
E.Borger,
L.Aitken,
S.J.Conway,
and
F.J.Gunn-Moore
(2010).
The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
|
| |
Biochem J, 426,
255-270.
|
 |
|
|
|
|
 |
K.E.van Straaten,
H.Zheng,
D.R.Palmer,
and
D.A.Sanders
(2010).
Structural investigation of myo-inositol dehydrogenase from Bacillus subtilis: implications for catalytic mechanism and inositol dehydrogenase subfamily classification.
|
| |
Biochem J, 432,
237-247.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Wu,
N.Liu,
Y.He,
and
Y.Chen
(2009).
Cloning, expression, and characterization of a novel diketoreductase from Acinetobacter baylyi.
|
| |
Acta Biochim Biophys Sin (Shanghai), 41,
163-170.
|
 |
|
|
|
|
 |
M.M.Hoque,
S.Shimizu,
M.T.Hossain,
T.Yamamoto,
S.Imamura,
K.Suzuki,
M.Tsunoda,
H.Amano,
T.Sekiguchi,
and
A.Takénaka
(2008).
The structures of Alcaligenes faecalis D-3-hydroxybutyrate dehydrogenase before and after NAD+ and acetate binding suggest a dynamical reaction mechanism as a member of the SDR family.
|
| |
Acta Crystallogr D Biol Crystallogr, 64,
496-505.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Ren,
H.W.Xu,
F.Davey,
M.Taylor,
J.Aiton,
P.Coote,
F.Fang,
J.Yao,
D.Chen,
J.X.Chen,
S.D.Yan,
and
F.J.Gunn-Moore
(2008).
Endophilin I expression is increased in the brains of Alzheimer disease patients.
|
| |
J Biol Chem, 283,
5685-5691.
|
 |
|
|
|
|
 |
A.T.Marques,
A.Antunes,
P.A.Fernandes,
and
M.J.Ramos
(2006).
Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
|
| |
BMC Genomics, 7,
202.
|
 |
|
|
|
|
 |
B.Youn,
R.Camacho,
S.G.Moinuddin,
C.Lee,
L.B.Davin,
N.G.Lewis,
and
C.Kang
(2006).
Crystal structures and catalytic mechanism of the Arabidopsis cinnamyl alcohol dehydrogenases AtCAD5 and AtCAD4.
|
| |
Org Biomol Chem, 4,
1687-1697.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Feller,
R.Günther,
H.J.Hofmann,
and
M.Grunow
(2006).
Molecular basis of substrate recognition in D-3-hydroxybutyrate dehydrogenase from Pseudomonas putida.
|
| |
Chembiochem, 7,
1410-1418.
|
 |
|
|
|
|
 |
K.Guo,
P.Lukacik,
E.Papagrigoriou,
M.Meier,
W.H.Lee,
J.Adamski,
and
U.Oppermann
(2006).
Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase.
|
| |
J Biol Chem, 281,
10291-10297.
|
 |
|
|
|
|
 |
M.Avadhani,
R.Geyer,
D.C.White,
and
L.J.Shimkets
(2006).
Lysophosphatidylethanolamine is a substrate for the short-chain alcohol dehydrogenase SocA from Myxococcus xanthus.
|
| |
J Bacteriol, 188,
8543-8550.
|
 |
|
|
|
|
 |
P.Inbar,
C.Q.Li,
S.A.Takayama,
M.R.Bautista,
and
J.Yang
(2006).
Oligo(ethylene glycol) derivatives of thioflavin T as inhibitors of protein-amyloid interactions.
|
| |
Chembiochem, 7,
1563-1566.
|
 |
|
|
|
|
 |
B.Youn,
S.G.Moinuddin,
L.B.Davin,
N.G.Lewis,
and
C.Kang
(2005).
Crystal structures of apo-form and binary/ternary complexes of Podophyllum secoisolariciresinol dehydrogenase, an enzyme involved in formation of health-protecting and plant defense lignans.
|
| |
J Biol Chem, 280,
12917-12926.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.J.Hosfield,
Y.Wu,
R.J.Skene,
M.Hilgers,
A.Jennings,
G.P.Snell,
and
K.Aertgeerts
(2005).
Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation.
|
| |
J Biol Chem, 280,
4639-4648.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Carlisle-Moore,
C.R.Gordon,
C.A.Machutta,
W.T.Miller,
and
P.J.Tonge
(2005).
Substrate recognition by the human fatty-acid synthase.
|
| |
J Biol Chem, 280,
42612-42618.
|
 |
|
|
|
|
 |
M.S.Alphey,
W.Yu,
E.Byres,
D.Li,
and
W.N.Hunter
(2005).
Structure and reactivity of human mitochondrial 2,4-dienoyl-CoA reductase: enzyme-ligand interactions in a distinctive short-chain reductase active site.
|
| |
J Biol Chem, 280,
3068-3077.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Y.Yang,
X.Y.He,
and
H.Schulz
(2005).
Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
|
| |
Trends Endocrinol Metab, 16,
167-175.
|
 |
|
|
|
|
 |
S.Yoon,
A.Smellie,
D.Hartsough,
and
A.Filikov
(2005).
Computational identification of proteins for selectivity assays.
|
| |
Proteins, 59,
434-443.
|
 |
|
|
|
|
 |
J.W.Lustbader,
M.Cirilli,
C.Lin,
H.W.Xu,
K.Takuma,
N.Wang,
C.Caspersen,
X.Chen,
S.Pollak,
M.Chaney,
F.Trinchese,
S.Liu,
F.Gunn-Moore,
L.F.Lue,
D.G.Walker,
P.Kuppusamy,
Z.L.Zewier,
O.Arancio,
D.Stern,
S.S.Yan,
and
H.Wu
(2004).
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
|
| |
Science, 304,
448-452.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Tieu,
C.Perier,
M.Vila,
C.Caspersen,
H.P.Zhang,
P.Teismann,
V.Jackson-Lewis,
D.M.Stern,
S.D.Yan,
and
S.Przedborski
(2004).
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
|
| |
Ann Neurol, 56,
51-60.
|
 |
|
|
|
|
 |
J.K.Yang,
M.S.Park,
G.S.Waldo,
and
S.W.Suh
(2003).
Directed evolution approach to a structural genomics project: Rv2002 from Mycobacterium tuberculosis.
|
| |
Proc Natl Acad Sci U S A, 100,
455-460.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Manoj,
E.Strauss,
T.P.Begley,
and
S.E.Ealick
(2003).
Structure of human phosphopantothenoylcysteine synthetase at 2.3 A resolution.
|
| |
Structure, 11,
927-936.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Bottoms,
P.E.Smith,
and
J.J.Tanner
(2002).
A structurally conserved water molecule in Rossmann dinucleotide-binding domains.
|
| |
Protein Sci, 11,
2125-2137.
|
 |
|
|
|
|
 |
C.W.Carter,
and
W.L.Duax
(2002).
Did tRNA synthetase classes arise on opposite strands of the same gene?
|
| |
Mol Cell, 10,
705-708.
|
 |
|
|
|
|
 |
D.H.Fong,
and
A.M.Berghuis
(2002).
Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.
|
| |
EMBO J, 21,
2323-2331.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.G.Milton,
N.P.Mayor,
and
J.Rawlinson
(2001).
Identification of amyloid-beta binding sites using an antisense peptide approach.
|
| |
Neuroreport, 12,
2561-2566.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|